Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel
Uitgebreid zoeken

Philips 2022

7.913 Posts
Pagina: «« 1 ... 232 233 234 235 236 ... 396 »» | Laatste | Omlaag ↓
  3. forum rang 10 bp5ah 15 september 2022 13:57

    • bp5ah

      Lid sinds: 13 apr 2001

      Laatste bezoek: 25 feb 2025

    • Aanbevelingen

      Ontvangen: 15814

      Gegeven: 18714

    •    Aantal posts: 59.273

    quote:

    nine_inch_nerd schreef op 15 september 2022 13:35:

    Rond ca minuut 30: Philips
    Plussen en minnen...
    youtu.be/FI0T1ltuBDE
    Te verwachten verhaal.

    Je hoeft geen haast te maken, de beurs is zenuwachtig genoeg.
  5. forum rang 9 nine_inch_nerd 15 september 2022 18:27

    • nine_inch_nerd

      Lid sinds: 04 feb 2015

      Laatste bezoek: 25 feb 2025

    • Aanbevelingen

      Ontvangen: 6931

      Gegeven: 5149

    •    Aantal posts: 17.812

    Laten we het eens over iets anders hebben...

    Philips highlights FetView cloud-based image sharing and reporting software for obstetrics and gynecology at ISUOG 2022
    September 15, 2022

    finance.yahoo.com/news/philips-highli...

    Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system, anytime and anywhere, to enhance diagnostic confidence for physicians and provide peace of mind for expectant mothers

    Amsterdam, the Netherlands and London, United Kingdom – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the upcoming addition of the FetView cloud-based fetal ultrasound image sharing and reporting software for obstetrics/gynecology (OB/GYN). As a vendor-neutral cloud-based platform for ultrasound images, FetView will utilize the ultrasound image data to convey fetal growth projections and provide a user-friendly platform for physician to physician and physician to patient communication.

    Philips Fetview is an integrated solution that combines fetal ultrasound imaging with enhanced reporting and easy access to an expectant mother’s medical data and fetal images. All results are securely stored and displayed in real time. With this upcoming addition of FetView into Philips’ advanced portfolio for Ultrasound in OB/GYN – which includes Lumify Handheld Ultrasound, diagnostic ultrasound systems EPIQ, Affiniti and mobile app Pregnancy+ – pregnant women and their care teams will have access to a comprehensive overview of how a pregnancy is progressing to help provide peace of mind to patients and enhance diagnostic confidence for clinicians.

    With OB/GYN ultrasounds performed in different clinical settings, immediate remote access to ultrasound images and medical histories for collaborative decision-making and easy sharing of images with patients is a challenge. Philips FetView will allow physicians to view, analyze, and annotate ultrasound images in real time via a cloud-based browser-accessible platform for secure image sharing, to help improve quality access to care, reduce patient mobility in case of high-risk pregnancies or post-surgery conditions, and reduce the need to rescan patients. By enabling full digitalization of OB/GYN workflows and patient management, Philips FetView will help drive greater departmental efficiency, reduce costs, and provide a better patient and staff experience.

    “I see multiple patients from many areas in my daily practice, and the implementation of FetView has meant a turbo boost in productivity for my practice,” said Prof. Alexander Scharf, Managing Director, MVZ PraenatGyn, Mainz, Germany. “The flexibility of the software is seamlessly integrated into my existing workflows and everything I need to access in the reporting is just one click away. FetView has also had a very positive impact on my patients, who have showed great enthusiasm for this program. The digital sharing of ultrasound images taken as part of prenatal care in accordance with data protection regulations and shared via a secure portal, help provide added peace of mind which is so important to expectant mothers.”

    “The cloud-based reporting and image sharing capabilities of Philips FetView enhance remote communication between physicians and patients,” said Matthijs Groot Wassink, General Manger, OB/GYN Ultrasound at Philips. “By digitizing the workflow, we are taking ultrasound to the next level, delivering smart ultrasound documentation to any OB/GYN practice. The digital reporting and image sharing, and fully customizable design are hugely helpful for physicians, helping to drive efficiency and cost savings with increasing patient satisfaction in their daily practice.”

    Philips FetView’s vendor-neutral software will retrieve images and measurement data via a secure encrypted DICOM interface and display them in a structured layout where care team members can easily add new information and data in line with their individual specialisms and produce easy-to-read growth curves. The application also streamlines the generation of reports in PDF format to be uploaded to electronic patient records and shared online with other clinicians and individual patients.

    Philips FetView will be featured with additional helping to drive earlier and more definitive diagnoses being showcased at this year’s International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress (September 16 – 18, 2022, London, U.K.). Philips is also hosting a Satellite Symposium [1] on September 16 at ISUOG 2022 (Hall 3, 12:30 – 13:30 BST), where international thought leaders, including Prof. Scharf, will discuss the future of obstetric and gynecological care and fetal medicine.

    [1] Available for 12 months after the event on the

    For further information, please contact:

    Kathy O’Reilly
    Philips Global Press Office
    Tel.: +1 978-221-8919
    E-mail :
    Twitter:

    About Royal Philips

    Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries. News about Philips can be found at .
  7. forum rang 10 bp5ah 16 september 2022 08:55

    • bp5ah

      Lid sinds: 13 apr 2001

      Laatste bezoek: 25 feb 2025

    • Aanbevelingen

      Ontvangen: 15814

      Gegeven: 18714

    •    Aantal posts: 59.273

    quote:

    €URO-Trader schreef op 16 september 2022 08:49:

    [...]wederom contrair of lineair omhoog/(omlaag)?
    ?? Geen idee, met de markt imo.
  10. forum rang 7 €URO-Trader 16 september 2022 10:39

    • €URO-Trader

      Lid sinds: 24 nov 2019

      Laatste bezoek: 25 feb 2025

    • Aanbevelingen

      Ontvangen: 2770

      Gegeven: 10624

    •    Aantal posts: 7.798

    Het is curieus, al ruim en jaar is men aan het repareren, met man en macht, ongetwijfeld laag betaalde uitzendkrachten, zo moeilijk is het nu ook weer niet las ik, dan kan kun he toch wel stellen dat men de eindfase benaderd. Of zijn het simpelweg gewoon onwaarheden die het kader van Philips naar buiten brengt, en is het Fd daarom pist-off?
  11. forum rang 10 bp5ah 16 september 2022 11:46

    • bp5ah

      Lid sinds: 13 apr 2001

      Laatste bezoek: 25 feb 2025

    • Aanbevelingen

      Ontvangen: 15814

      Gegeven: 18714

    •    Aantal posts: 59.273

    quote:

    nine_inch_nerd schreef op 16 september 2022 10:29:

    Volgt de markt momenteel...
    Idd.

    't is elke dag een verrassing momenteel.

    Lijkt eerder weer contrair te gaan ...
  13. forum rang 10 bp5ah 16 september 2022 17:09

    • bp5ah

      Lid sinds: 13 apr 2001

      Laatste bezoek: 25 feb 2025

    • Aanbevelingen

      Ontvangen: 15814

      Gegeven: 18714

    •    Aantal posts: 59.273

    quote:

    sportliefhebber schreef op 16 september 2022 17:03:

    Wat zo'n kop bij IEX al niet kan doen voor de koers:
    Miljardenclaim VEB tegen Philips belachelijk.
    En dat is het ook.
    Philips is net als 't weer momenteel, beetje wisselend ....
  14. [verwijderd] 16 september 2022 17:20

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    sportliefhebber schreef op 16 september 2022 17:03:

    Wat zo'n kop bij IEX al niet kan doen voor de koers:
    Miljardenclaim VEB tegen Philips belachelijk.
    En dat is het ook.
    Gezien de omzet het laatste uur lijkt het eerder op een grote koper die nog voor het weekend wil toeslaan.
  17. forum rang 10 bp5ah 16 september 2022 17:36

    • bp5ah

      Lid sinds: 13 apr 2001

      Laatste bezoek: 25 feb 2025

    • Aanbevelingen

      Ontvangen: 15814

      Gegeven: 18714

    •    Aantal posts: 59.273

    quote:

    nine_inch_nerd schreef op 16 september 2022 17:31:

    Bij de 5 AEX groenen vandaag.
    Zegt nog niks, maar wel fijn!
    18.08 slot 36 miljoen vol !!!
7.913 Posts
Pagina: «« 1 ... 232 233 234 235 236 ... 396 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.018
AB InBev 2 5.501
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.680
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 265
Accsys Technologies 23 10.703
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 189
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.752
Aedifica 3 916
Aegon 3.258 322.856
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.893
Agfa-Gevaert 14 2.050
Ahold 3.538 74.339
Air France - KLM 1.025 35.047
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.041
Alfen 16 24.862
Allfunds Group 4 1.473
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.250
AMG 971 133.370
AMS 3 73
Amsterdam Commodities 305 6.690
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.008
Apollo Alternative Assets 1 17
Apple 5 382
Arcadis 252 8.780
Arcelor Mittal 2.033 320.715
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.302
Aroundtown SA 1 219
Arrowhead Research 5 9.741
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.150
ASML 1.766 107.472
ASR Nederland 21 4.486
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.674
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392

Macro & Bedrijfsagenda

  1. 25 februari

    1. Ackermans & Van Haaren Q4-cijfers
    2. Economische groei vierde kwartaal def (Dld)
    3. Home Depot Q4-cijfers (VS)
    4. Case Shiller huizenprijzen december (VS)
    5. Consumentenvertrouwen CB maart (VS)
    6. ASMI Q4-cijfers volitaliteit verwacht
    7. AMC Entertainment Q4-cijfers (VS)

  2. 26 februari

    1. JDE Peet's Q4-cijfers
    2. Wolters Kluwer Q4-cijfers
    3. AB InBev Q4-cijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht
Naar de hele agenda